TRESIBA

Novo Nordisk Canada Inc🇨🇦 Health Canada

Approval Id: 6eeb3d32bc68414b
Drug Approval Canada Name: TRESIBA
Product Name: TRESIBA
Status: Marketed
Status Date: 2017-09-15
Original Market Date: 2017-09-15
Din: 02467887
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D
Ahfs: 68:20.08.16
Atc Original: A10AE06 INSULIN DEGLUDEC
Atc Name: a 10 ae 06
Aig Number: 0159410002
Company Name: Novo Nordisk Canada Inc
Company Address: 101-2476 Argentia Road, Mississauga, Ontario, Canada, L5N 6M1

INSULIN DEGLUDEC

200 UNIT / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

6eeb3d32bc68414b

Type

Standard